newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics to Participate in the 23rd Annual H.C. Wainwright Global Investment Conference

STANS, SWITZERLAND / ACCESSWIRE / September 8, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients